Production and application of LPA polyclonal antibody

被引:20
作者
Chen, JH [1 ]
Zou, F [1 ]
Wang, ND [1 ]
Xie, SW [1 ]
Zhang, X [1 ]
机构
[1] Peking Univ, Dept Chem, Minist Educ, Key Lab Bioorgan Chem & Mol Engn, Beijing 100871, Peoples R China
基金
中国国家自然科学基金;
关键词
D O I
10.1016/S0960-894X(00)00325-5
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
By using colloidal gold as a hapten carrier, a kind of antibody against lysophosphatidic acid (LPA) was developed and used to successfully detect 500 ng/mL LPA in dot immunogold filtration assay. Such application of the LPA antibody could offer us a way to diagnose ovarian cancer at its early stage. (C) 2000 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1691 / 1693
页数:3
相关论文
共 10 条
[1]   A METHOD FOR THE PRODUCTION OF HIGHLY SPECIFIC POLYCLONAL ANTIBODIES [J].
DIANO, M ;
LEBIVIC, A ;
HIRN, M .
ANALYTICAL BIOCHEMISTRY, 1987, 166 (01) :224-229
[2]   GROWTH FACTOR-LIKE EFFECTS OF LYSOPHOSPHATIDIC ACID, A NOVEL LIPID MEDIATOR [J].
JALINK, K ;
HORDIJK, PL ;
MOOLENAAR, WH .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1994, 1198 (2-3) :185-196
[3]   LYSOPHOSPHATIDIC ACID, A MULTIFUNCTIONAL PHOSPHOLIPID MESSENGER [J].
MOOLENAAR, WH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (22) :12949-12952
[4]  
Moolenaar Wouter H., 1994, Trends in Cell Biology, V4, P213, DOI 10.1016/0962-8924(94)90144-9
[5]  
SVENDSEN L, 1995, LAB ANIM SCI, V45, P89
[6]  
Tatsumi Noriyuki, 1993, Osaka City Medical Journal, V39, P167
[7]  
TIGYI G, 1992, J BIOL CHEM, V267, P21360
[8]   LYSOPHOSPHATIDIC ACIDS INDUCE PROLIFERATION OF CULTURED VASCULAR SMOOTH-MUSCLE CELLS FROM RAT AORTA [J].
TOKUMURA, A ;
IIMORI, M ;
NISHIOKA, Y ;
KITAHARA, M ;
SAKASHITA, M ;
TANAKA, S .
AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 267 (01) :C204-C210
[9]   Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers [J].
Xu, Y ;
Shen, ZZ ;
Wiper, DW ;
Wu, MZ ;
Morton, RE ;
Elson, P ;
Kennedy, AW ;
Belinson, J ;
Markman, M ;
Casey, G .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (08) :719-723
[10]  
Xu Y, 1995, CLIN CANCER RES, V1, P1223